April 6, 2021
Via: CNBCPresident Joe Biden announced Tuesday that states should open Covid-19 vaccine appointments to all U.S. adults by April 19, moving up his original deadline by nearly two weeks. Biden announced the new deadline after he visited a vaccination site in […]
Biotech, Cell and Gene Therapy, Industry
April 6, 2021
Via: BioSpaceShanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted […]
Biotech, Industry, Manufacturing, News, Research and Development, Vaccines
April 5, 2021
Via: BioSpaceEmergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]
April 2, 2021
Via: BioSpaceCOVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]
Clinical Trials, News, Research and Development
April 2, 2021
Via: ScienceDailyA team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. […]
April 1, 2021
Via: Biopharma DiveThe FDA’s emergency authorization of J&J’s vaccine late last month boosted the quickening rollout of vaccines in the U.S., adding a third option in addition to shots from Pfizer and Moderna. Yet, previous delays in manufacturing meant J&J only had […]
Industry, Manufacturing, Research and Development, Vaccines
March 29, 2021
Via: World Pharma NewsEMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU. New manufacturing site for AstraZeneca’s COVID-19 vaccine A new manufacturing site has been approved for the production […]
March 19, 2021
Via: BioSpaceThrombosis Canada has reviewed recent reports from the United Kingdom and Europe relating to the SARS-CoV-2 (COVID-19) vaccine made by AstraZeneca and the development of a very rare type of thrombosis (blood clots) that is associated with thrombocytopenia (low blood […]
Clinical Trials, Industry, Research and Development, Vaccines
March 17, 2021
Via: BioSpaceTonix Pharmaceuticals, Inc.. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox virus, live vaccine), a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 […]
March 17, 2021
Via: Genetic Engineering and Biotechnology NewsWith treatments for COVID-19 lacking, researchers are homing in on drugs that are already FDA approved to search for candidates that may inhibit SARS-CoV-2 replication. This method, known as repurposing, has found that clofazimine, an anti-leprosy drug, exhibits potent antiviral […]
March 15, 2021
Via: CNBCSix members of the European Union have raised concerns over how the bloc is distributing Covid-19 vaccines, after AstraZeneca cut its delivery targets once again. Austria, Latvia, the Czech Republic, Bulgaria, Croatia and Slovenia wrote to the European Commission on […]
March 10, 2021
Via: CNBCThe European Union and the United Kingdom have clashed over the export of coronavirus vaccines, with Britain fiercely denying it has blocked any shipments to other nations. The latest battle emerged after European Council President Charles Michel accused the U.K. […]
Copyright © 2021. All rights reserved
